SCHEMBL177845

SCHEMBL177845

NC(=O)CCCS(=O)(=O)O.[NaH]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.52
CYP2C19 P33261 3/20 0.43
BLM P54132 3/20 0.43
LMNA P02545 2/20 0.43
SLC6A6 P31641 1/20 0.43
PTGS1 P23219 1/20 0.38
PDE4A P27815 1/20 0.38
KMT2A Q03164 2/20 0.31
TP53 P04637 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
MEN1 O00255 1/20 0.31
FAAH O00519 1/20 0.31
SOAT1 P35610 1/20 0.31
ALOX15 P16050 2/20 0.31
PMP22 Q01453 2/20 0.31
APEX1 P27695 1/20 0.31
EPHX2 P34913 1/20 0.31
KDM4E B2RXH2 1/20 0.30
GMNN O75496 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL177559 0.97 APP (0.55) APPCYP2C19BLMLMNASLC6A6
SCHEMBL177764 0.95 APP (0.52) APPCYP2C19BLMLMNASLC6A6
SCHEMBL8592959 0.90 APP (0.52) APPCYP2C19BLMLMNASLC6A6
SCHEMBL20902773 0.87 APP (0.50) APPCYP2C19BLMLMNASLC6A6
SCHEMBL19569862 0.87 APP (0.50) APPCYP2C19BLMLMNASLC6A6
SCHEMBL9702032 0.87 APP (0.50) APPCYP2C19BLMLMNASLC6A6
SCHEMBL177593 0.86 BLM (0.46) APPCYP2C19BLMLMNASLC6A6
SCHEMBL177492 0.83
SCHEMBL177490 0.81 BLM (0.46) APPCYP2C19BLMLMNASLC6A6
SCHEMBL29045770 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2386538-B1 N-(1-HYDROXYETHYL)CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME SHOWA DENKO KK (JP) 2015-07-29 EP disclosed
US-8697912-B2 N-(1-hydroxyethyl) carboxamide compound and process for producing same SHOWA DENKO K.K. (JP) 2014-04-15 US disclosed
US-20110294974-A1 N-(1-HYDROXYETHYL ) CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME SHOWA DENKO K.K. (JP) 2011-12-01 US disclosed
EP-2386538-A1 N-(1-HYDROXYETHYL)CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME Showa Denko K.K. (JP) 2011-11-16 EP disclosed
EP-0473881-B1 Liquid absorption agent SHOWA DENKO KK (JP) 2001-11-07 EP disclosed
US-6166253-A Process for producing N-(1-alkoxyethyl)carboxylic amides SHOWA DENKO K.K. (JP) 2000-12-26 US disclosed
EP-0799820-B1 Process producing n-(1-alkoxyethyl)carboxylic amides SHOWA DENKO KK (JP) 2000-11-02 EP disclosed
US-5852214-A Process for producing n-(1-alkoxyethyl) carboxylic amides SHOWA DENKO K.K. (JP) 1998-12-22 US disclosed
US-5788950-A Method for the synthesis of mixed metal oxide powders SHOWA DENKO K.K. (JP) 1998-08-04 US disclosed
US-5744118-A MIXING ABSORBENT RESIN AND METAL SALTS, SWELLING AND GELATION, ADJUSTMENT OF PH, PYROLYSIS AND ROASTING SHOWA DENKO K.K. (JP) 1998-04-28 US disclosed
EP-0799820-A1 Process producing n-(1-alkoxyethyl)carboxylic amides SHOWA DENKO KABUSHIKI KAISHA (JP) 1997-10-08 EP disclosed
EP-0510246-B1 Use of fine particulate crosslinked type n-vinylamide resin microgel SHOWA DENKO KK (JP) 1996-09-25 EP disclosed
US-5407996-A Contacting with an aqueous solution of metal ion or metal oxide to form a gel; calcining SHOWA DENKO K.K. (JP) 1995-04-18 US disclosed
US-5338815-A Used in thickeners, dispersion stabilizers and lubricants SHOWA DENKO K.K. (JP) 1994-08-16 US disclosed
US-5300606-A Crosslinked N-vinylamide resin SHOWA DENKO K.K. (JP) 1994-04-05 US disclosed
US-5280095-A N-vinylcarboxylic acid amine resin SHOWA DENKO K.K. (JP) 1994-01-18 US disclosed
EP-0510246-A1 Use of fine particulate crosslinked type n-vinylamide resin microgel SHOWA DENKO KABUSHIKI KAISHA (JP) 1992-10-28 EP disclosed
EP-0473881-A1 Liquid absorption agent SHOWA DENKO KABUSHIKI KAISHA (JP) 1992-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294974-A1 N-(1-HYDROXYETHYL ) CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME ADH1A, ADH1C, CNKSR1 APP 3888/4885CYP2C19 1138/4885BLM 3940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.